Latest muscular dystrophy Stories
Leading Duchenne organizations partner to enable long-term trials of novel anti-inflammatory drug; chronic toxicology studies will pave regulatory path to Phase 2a studies later this year
PPMD's Annual Advocacy Conference Focused on Implementing MD-CARE Act Amendments & Strengthening Patient Voice at FDA WASHINGTON, Feb.
Product holds potential for replacing glucocorticoids in Duchenne muscular dystrophy and other chronic inflammatory states SILVER SPRING, Md. and CHICAGO, Feb.
SAN DIEGO, Feb. 18, 2015 /PRNewswire/ -- aTyr Pharma, Inc.
#MDAshamrocks CHICAGO, Feb.
HACKENSACK, N.J., Feb.
Through March 30, Lowe’s customers can help accelerate progress for children and adults affected by muscle disease by adding a paper shamrock to their purchase at checkout for just $1, $5 or
Leading Duchenne Organization Continues to Certify Top Clinics Nationally HACKENSACK, N.J., Feb.
Researchers at Nationwide Children's Hospital have developed a way to measure upper extremity movement in patients with muscular dystrophy using interactive video game technology. Their hope is to expand inclusion criteria for clinical trials to incorporate patients using wheelchairs.
HACKENSACK, N.J., Jan.